CIBINQO
NDC 63539-336, abrocitinib, tablet, film coated, from U.S. Pharmaceuticals.
- Product NDC
- 63539-336
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213871
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-336 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABROCITINIB100 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-336-14 | 63539033614 | 14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/16c12a56-4550-414b-ac9d-b785b41fea6b
Use it
Look up 63539-336 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-336 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-336. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.